Sign in

CIK 0001651308

  • Large accelerated filer

BeOne Medicines Ltd.

Sign in to watch
Ticker
BEIGF
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
981209416
Phone
+41 616851900
Business address
C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
Former names
BeiGene, Ltd.

Securities

  • ONC American Depositary Shares Nasdaq
  • BEIGF Common stock OTC
  1. 3 Insider Initial Statement of Ownership
  2. 4 Open-market sale CMO, Hematology sold 1,500 shares at an average $324.00 ($485,993)
  3. 4 Gift Director gave 80,000 shares (gift)
  4. 4 Open-market sale CMO, Hematology sold 1,500 shares at an average $320.73 ($481,099)
  5. 4 Open-market sale CMO, Hematology sold 1,500 shares at an average $322.99 ($484,492)
  6. 4 Open-market sale CFO & Chief Strategy Officer sold 14,000 shares at an average $344.85 ($4,827,945)
  7. 4 Open-market sale Director sold 121,154 shares at $220.50 ($26,714,457)
  8. 4 Open-market sale CMO, Hematology sold 1,500 shares at an average $249.13 ($373,690)
  9. 4 Grant or award 10% owner acquired 25,762 shares (grant or award)
  10. 4 Grant or award 10% owner acquired 228,138 shares (grant or award)
  11. 4 Gift Director gave 165,295 shares (gift)
  12. 4 Open-market sale CFO & Chief Strategy Officer sold 91,900 shares at an average $229.04 ($21,048,454)
  13. 4 Gift Chief Executive Officer gave 2,136,914 shares (gift)
  14. 4 Gift Director gave 1,332,552 shares (gift)
  15. 4 Gift Director gave 589,849 shares (gift)
  16. 4 Open-market sale Director sold 1,511,546 shares at $220.50 ($333,295,893)
  17. 4 Open-market sale CMO, Hematology sold 1,500 shares at an average $267.82 ($401,723)
  18. 4 Open-market sale CMO, Hematology sold 1,500 shares at an average $300.06 ($450,093)
  19. 4 Open-market sale Director sold 5,000 shares at $320.00 ($1,600,000)
  20. 4 Open-market sale Director sold 5,000 shares at $300.00 ($1,500,000)

Page 17 of 29 · 580 filings